On March 27, 2026, the conference “Pharmacovigilance: Opportunities for Dialogue Between Healthcare Organizations and the Pharmaceutical Industry to Ensure Patient Safety” was held at the Russian University of Medicine (Moscow). The event brought together representatives of regulatory authorities, experts in clinical pharmacology, and pharmaceutical industry experts.

The conference was organized by the K.M. Lakin Scientific and Educational Institute of Pharmacy and the independent research organization Institute of Clinical and Economic Expertise and Pharmacoeconomics LLC, with the support of the Association of Clinical Pharmacologists and the Association of International Pharmaceutical Manufacturers (AIPM).

The business program focused on the organization of effective pharmacovigilance systems in healthcare organizations and marketing authorization holders, as well as interaction with regulators under the requirements of the EAEU.

Experts from “Pharmcompliance” gave presentations to the professional community:

• Anna Vyacheslavovna Kashirskikh, General Director of the Pharmacovigilance Agency “Pharmcompliance” LLC, presented on the topic “Preparation for Pharmacovigilance Inspections.” In her talk, she detailed the key aspects of company readiness for inspections by regulatory authorities, focusing on common mistakes and effective strategies for passing inspections;
• Ivan Sergeevich Anosov, Ph.D. in Pharmaceutical Sciences, Executive Director of the Pharmacovigilance Agency “Pharmcompliance” LLC, gave a presentation on “Education and Training in Pharmacovigilance.” His talk covered modern approaches to training personnel in the field of pharmacovigilance, the importance of continuous professional development, and the implementation of educational programs to enhance the competencies of industry specialists